miR-550-1 functions as a tumor suppressor in acute myeloid leukemia via the hippo signaling pathway
Cited by 18
Related Papers
PP2A inhibition from LB100 therapy enhances daunorubicin cytotoxicity in secondary acute myeloid leukemia via miR-181b-1 upregulation
|Scientific Reports|2017|22
MAP4K1 functions as a tumor promotor and drug mediator for AML via modulation of DNA damage/repair system and MAPK pathway
|EBioMedicine|2021|20
m<sup>6</sup>A‐dependent upregulation of DDX21 by super‐enhancer‐driven IGF2BP2 and IGF2BP3 facilitates progression of acute myeloid leukaemia
|Clinical and Translational Medicine|2024|20
Ganoderic acid A ameliorates non‑alcoholic streatohepatitis (NASH) induced by high‑fat high‑cholesterol diet in mice
|Experimental and Therapeutic Medicine|2022|14